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Abstract
Expression of co-inhibitory molecules is generally associated with T-cell dysfunction in chronic viral infections such as HIV or
HCV. However, their relative contribution in the T-cell impairment remains unclear. In the present study, we have evaluated
the impact of the expression of co-inhibitory molecules such as 2B4, PD-1 and CD160 on the functions of CD8 T-cells specific
to influenza, EBV and CMV. We show that CD8 T-cell populations expressing CD160, but not PD-1, had reduced proliferation
capacity and perforin expression, thus indicating that the functional impairment in CD160+ CD8 T cells may be independent
of PD-1 expression. The blockade of CD160/CD160-ligand interaction restored CD8 T-cell proliferation capacity, and the
extent of restoration directly correlated with the ex vivo proportion of CD160+ CD8 T cells suggesting that CD160 negatively
regulates TCR-mediated signaling. Furthermore, CD160 expression was not up-regulated upon T-cell activation or
proliferation as compared to PD-1. Taken together, these results provide evidence that CD160-associated CD8 T-cell
functional impairment is independent of PD-1 expression.
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Introduction
Co-stimulatory and co-inhibitory molecules play a major role in
the regulation of antigen-specific T-cell responses [1]. Following
T-cell receptor (TCR) engagement, activation or inhibition of T-
cell responses depends upon the balance between stimulatory and
inhibitory signals, on the type of molecules engaged or ligands
involved and the availability of signaling molecules [2–4].
Co-stimulatory/co-inhibitory molecules are commonly divided
into 4 families: 1) the B7 family including CD28, Cytotoxic T-
lymphocyte associated protein-4 (CTLA-4), Programmed Death
receptor-1 (PD-1), Inducible T-cell Costimulator (ICOS) and B-
and T-lymphocyte attenuator (BTLA), 2) TNF-a receptor family
including CD27, 3) the CD2/SLAM family, including Signaling
Lymphocyte Activation Molecule (SLAM), 2B4 and CD48 and 4)
the immunoglobulin (Ig) family including T-cell Immunoglobulin
mucin-3 (TIM-3), lymphocyte Activation Gene-3 (LAG-3) and
CD160 [5–10]. Each co-inhibitory/stimulatory molecule interacts
with one or several receptors expressed by one or various cell types
(reviewed in [2]).
During the past decade, many studies performed in mice and
humans have underscored the role of co-inhibitory molecules in
the functional impairment (also called ‘‘exhaustion’’) of antigen-
specific T cells during chronic viral infections such as human
immunodeficiency virus-1 (HIV-1) or hepatitis C virus (HCV) [11–
14]. In these virus chronic infections, the early functional
impairment of T cells was marked by the loss of proliferation
capacity likely resulting from reduced capacity to produce IL-2
and a deficient killing capacity of CD8 T cells. The ability to
produce TNF-a was generally observed at an intermediate state of
T-cell exhaustion while the loss of IFN-c occurred in the advanced
stage of T-cell exhaustion [15,16].
Recent studies have demonstrated that HIV-specific CD8 T
cells co-expressing several co-inhibitory molecules such as PD-1,
CD160 and 2B4 were significantly more functionally impaired
than CD8 T cells expressing only one co-inhibitory molecule [17–
19]. However, the relative contribution of each co-inhibitory
molecule has not yet been fully delineated.
In the present study, we evaluated the impact of the expression of
co-inhibitory molecules such as 2B4, PD-1 and CD160 on CD8 T-
cells specific to influenza (Flu), Epstein Barr virus (EBV) and
cytomegalovirus (CMV). We demonstrated that CD160+ CD8 T cells
had reduced proliferation capacity, IL-2 production and perforin
expression regardless of PD-1 expression thus providing evidence that
CD160-associated T-cell impairment is independent of PD-1.
Results
EBV and CMV-specific CD8 T cells express significantly
higher levels of CD160 than Flu-specific CD8 T cells
The expression of PD-1, 2B4, and CD160 co-inhibitory
molecules was assessed by multiparametric flow cytometry in
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CMV-, EBV- and Flu-specific CD8 T cells from 22 healthy
individuals ex vivo using peptide-MHC class I multimer complexes
(Table 1). The gating strategy defining the positivity of co-inhibitory
molecule expression was set by fluorescence minus one (FMO) for all
co-inhibitory molecules tested (Fig. S1). The use of 2B4, PD-1 and
CD160 co-inhibitory molecules expression allowed the identification
of 6 major CD8 T-cell populations i.e. 2B4+CD160+PD-1+,
2B4+CD160+PD-12, 2B4+CD1602PD-1+, 2B4+CD1602PD-12,
2B42CD1602PD-1+ and 2B42CD1602PD-12 CD8 T-cell popula-
tions. The 2B42CD160+PD-1+ and 2B42CD160+PD-12 CD8
T-cell populations are minor populations and represent less than
0.05% and 0.5% of virus-specific CD8 T cells, respectively, and were
not included in the additional analyses shown below. Representative
flow cytometry profiles and cumulative data (n = 30) showed that
CMV and EBV-specific CD8 T cells expressed significantly higher
levels of 2B4 (P= 0.0003 and P= 0.0015, respectively) and CD160
(P,0.0001 and P= 0.0022, respectively) as compared to Flu-specific
CD8 T cells (Fig. 1A and B). Interestingly, no significant differences
were observed in PD-1 expression between CMV, EBV and Flu-
specific CD8 T cells in the cohort of subjects investigated in the
present study (Fig. 1A and B). However, the proportion of
2B4+CD160+PD-1+ and 2B4+CD160+PD-12 cells were significantly
higher in CMV and EBV-specific CD8 T cells than in Flu-specific
CD8 T cells (P,0.025) (Fig. 1C). Of note, mean fluorescent intensity
(MFI) of CD2B4, CD160 and PD-1 was not significantly different
between FLU, EBV and CMV-specific CD8 T cells (Fig. S2). Flu-
specific CD8 T cells were mainly composed of 2B42CD1602PD-12,
2B42CD1602PD-1+ and 2B4+CD1602PD-1+ CD8 T-cell popula-
tions (Fig. 1C). Interestingly, the co-inhibitory molecule expression
profile of CMV and EBV-specific CD8 T cells was heterogeneous but
not significantly different (P.0.05).
CD160 but not PD-1 and/or 2B4 expression negatively
correlates with CD8 T-cell proliferative capacity
As mentioned above, CD8 T-cell proliferation capacity is one of
the first function lost during CD8 T-cell functional impairment
[11–14,20]. The proliferation capacity of Flu, EBV and CMV-
specific CD8 T cells was then assessed using the CFSE flow
cytometry assay. To normalize according to the initial frequency
of virus-specific CD8 T cells, virus-specific CD8 T-cell prolifer-
ation capacity was represented in proliferation index, defined as
the ratio of the virus-specific CD8 T-cell proliferation capacity
(percentage of CFSE low CD8 T cells) and the ex vivo frequency
of virus-specific CD8 T cells (measured by MHC class I multimer
staining). The representative flow cytometry profiles and the
cumulative data showed that the proliferation index of Flu-specific
CD8 T cells was significantly higher than that of EBV and CMV-
specific CD8 T cells (Fig. 2 A–E). We then evaluated the potential
association between the ex vivo expression pattern of co-inhibitory
molecules expression and the proliferation index of virus-specific
CD8 T cells. We showed that the ex vivo proportion of CD160,
2B4 but not PD-1 inversely correlated with the proliferation index
of virus-specific CD8 T cells (r =20.7605; P,0.0001, r =
20.5248; P= 0.0049, and r = 0.1002; P = 0.6192, respectively)
(Fig. S3). We then assessed whether certain combinations of co-
inhibitory molecules expression would be specifically associated
with the proliferation index of virus-specific CD8 T cells. We
showed that the ex vivo proportion of 2B4+CD160+PD-1+ or
2B4+CD160+PD-12 virus-specific CD8 T cells inversely correlated
with the proliferation index of virus-specific CD8 T cells (r =
20.72; P,0.0001 and r =20.62; P= 0.0004, respectively)
(Fig. 2F). In addition, the proliferation index of virus-specific
CD8 T cells did not inversely correlate with the proportion of
CD1602 CD8 T-cell populations (Fig. 2F). These data suggest
that the proliferation capacity of virus-specific CD8 T cells may be
negatively regulated by CD160 expression independently of PD-1
expression.
Proliferative capacity virus-specific CD8 T-cell
populations is influenced by co-inhibitory molecule
expression
To determine the impact of co-inhibitory signals on virus-specific
CD8 T-cell proliferation capacity, CD8 T-cell populations were sorted
based on PD-1, 2B4 and CD160 expression. Of note, naı¨ve CD8 T
cells (CD45RA+CCR7+) were excluded from the analysis. Cell
populations were then stimulated with (viral) peptides in the presence
of antigen presenting cells (CD8-depleted PBMCs) for 6 days (Fig. 3).
Author Summary
T-cell immune response is regulated by a variety of
molecules known as co-inhibitory receptors. The over
expression of co-inhibitory receptors has been observed in
several chronic viral infections such as HIV disease, and is
found to be associated with severe T-cell dysfunction.
Recent studies have demonstrated that the co-expression
of several co-inhibitory receptors correlated with greater
impairment of CD8 T cells. However, the relative contri-
bution of individual co-inhibitory receptors to the regula-
tion of T-cell functions remains unclear. In order to shed
light on these issues, we have evaluated the influence of
the expression of 3 major co-inhibitory receptors such as
PD-1, 2B4 and CD160 on CD8 T-cell functions such as
proliferation, cytokines production and expression of
cytotoxic granules. We demonstrate that CD160-associated
CD8 T-cell functional impairment is independent of PD-1
expression and that the blockade of CD160 signaling may
partially restore CD8 T-cell functions.
Table 1. Sequences of peptides used for CD8 T-cell stimulations and multimer staining.
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The proliferation capacity of Flu, EBV and CMV-specific CD8 T cells
was then assessed using the CFSE flow cytometry assay and normalized
according to the initial frequency of virus-specific CD8 T cells within
each CD8 T-cell population (i.e. 2B4+CD160+PD-1+,
2B4+CD160+PD-12, 2B4+CD1602PD-1+, 2B4+CD1602PD-12,
2B42CD1602PD-1+ and 2B42CD1602PD-12 CD8 T-cell popula-
tions). The representative flow cytometric profiles as well as the
cumulative data show that the proliferation capacity of virus-specific
2B4+CD160+PD-1+, 2B4+CD160+PD-12, 2B4+CD1602PD-1+,
2B4+CD1602PD-12CD8 T-cell populations was significantly reduced
as compared to 2B42CD1602PD-1+ and 2B42CD1602PD-12 CD8
T-cell populations (P,0.05) (Fig. 3A–B). Of note, the proliferation
capacity of 2B4+CD1602PD-12 and 2B42CD160+PD-1+ CD8 T cells
was not significantly different (P= 0.0628) (Fig. 3B). These data suggest
that the proliferation capacity of virus-specific CD8 T cells is influenced
by co-inhibitory molecule expression.
CD8 T-cell populations expressing CD160 harbor reduced
proliferative capacity, independently of PD-1 expression
To determine the intrinsic CD8 T-cell proliferation capacity,
CD8 T-cell populations were sorted based on PD-1, 2B4 and
CD160 expression. Of note, naı¨ve CD8 T cells
(CD45RA+CCR7+) were excluded from the analysis. Cell popu-
lations were then stimulated with coated anti-CD3 and anti-CD28
MAbs for 6 days, and the proliferation capacity was assessed using
CFSE flow cytometry based assay (Fig. 4). The representative flow
cytometric profiles and the cumulative data showed that the
proliferation capacity of CD160 and/or PD-1-expressing CD8 T
cells was significantly reduced as compared to CD160 and PD-1
negative CD8 T-cell populations (P,0.05) (Fig. 4). Interestingly,
the proliferation capacity of 2B4+CD160+PD-1+ and
2B4+CD160+PD-12 CD8 T cells was not significantly different
(P= 0.6786), suggesting that CD160-expessing CD8 T cells are
endowed with reduced proliferation capacity, independently of
PD-1 expression.
CD160 but not PD-1 expression is strongly associated
with reduced IL-2 production
In chronic virus infections the loss of CD8 T-cell proliferative
capacity is commonly associated with a progressive reduction of IL-
2 production [15,16]. Production of IFN-c is affected generally at
advanced stages of T-cell exhaustion [15,16]. IL-2 and IFN-c
production were then evaluated by flow cytometry in memory CD8
T-cell populations defined by PD-1, 2B4 and CD160 expression. Of
note, the naı¨ve CD8 T-cell population (CD45RA+CCR7+) was
excluded from this analysis. The representative flow cytometric
profiles as well as the cumulative data showed that the frequencies of
IL-2 and IFN-c-producing cells were significantly reduced in
CD160+ CD8 T-cell populations as compared to CD1602 CD8 T-
cell populations (P,0.05) (Fig. 5A–C). The frequencies of both IL-2
and IFN-c-producing cells were not significantly different between
2B4+CD160+PD-1+ and 2B4+CD160+PD-12 CD8 T-cell popula-
tions (P= 0.998 and P= 0.470, respectively) and between
2B4+CD1602PD-1+ and 2B4+CD1602PD-12 CD8 T-cell popula-
tions (P= 0.888 and P= 0.908, respectively) (Fig. 5A–C). In
addition, 2B42CD1602PD-1+ CD8 T-cell populations contained
higher frequencies of IL-2-producing cells than any other CD8 T-
cell population (P,0.05) (Fig. 5A–C), demonstrating that CD160
and not PD-1 expression on memory CD8 T cells is strongly
associated with reduced IL-2 and IFN-c production capacity.
Co-inhibitory molecule expression is associated with the
differentiation state
Reduced IL-2 production capacity is commonly associated with
increased differentiation state [21]. In this context, we assessed the
potential association between co-inhibitory molecule expression and
differentiation state. To that purpose, the differentiation state was
evaluated using the expression of CD45RA and CCR7. The
representative flow cytometric profiles as well as the cumulative data
showed that 2B4, CD160 and PD-1 expression significantly increased
with the differentiation state, confirming the recent findings from
Legat and colleagues [22] (Fig. 6A–B). However, in-depth analyses
showed that CD8 T-cell populations defined by 2B4, CD160 and/or
PD-1 expression were heterogeneously distributed among the distinct
differentiated CD8 T-cell subsets (Fig. 6C). Indeed, the central
memory compartment (CM; CD45RA2CCR7+) was significantly
enriched in 2B42CD1602PD-12 and 2B42CD1602PD-1+ CD8 T-
cell populations, the effector memory compartment (EM;
CD45RA2CCR72) was significantly enriched in PD-1+ CD8 T-cell
populations (2B4+CD160+PD-1+, 2B4+CD1602PD-1+ and
2B42CD1602PD-1+ CD8 T-cell populations) and the terminally
differentiated effector memory compartment (TDEM;
CD45RA+CCR72) was significantly enriched in the
2B4+CD160+PD-12 CD8 T-cell population (P,0,05) (Fig. 6C).
These data suggest that co-inhibitory molecule expression is
associated with differentiation state. However in depth analyses
further indicated that significant differences are present within each
CD8 T-cell populations, particularly among PD-1 and/or CD160-
expressing populations.
CD160 but not PD-1 expression is strongly associated
with reduced perforin expression
Since perforin expression is the hallmark of differentiated CD8
T cells [21], we then assessed whether 2B4+CD160+PD-1+ and
2B4+CD160+PD-12 CD8 T-cell populations were enriched in
perforin or granzyme B. Indeed, cytotoxic CD8 T cells exert their
antiviral activity primarily through the secretion of cytotoxic
granules containing perforin and granzymes [23,24]. Therefore,
the expression of perforin and granzyme B was evaluated in CD8
T-cell populations defined by the expression of PD-1, 2B4 and/or
Figure 1. EBV and CMV-specific CD8 T cells express significantly more CD160 than Flu-specific CD8 T cells. Flow cytometric profiles of
Flu, EBV and CMV-specific CD8 T cells expressing PD-1, CD160 and 2B4 ex vivo. The expression profiles of CD8 T cells were performed in 22 individuals
using polychromatic flow cytometry. (A) 2B4, CD160 and PD-1 expression profiles of Flu, EBV and CMV-specific CD8 T cells detected by multimer
staining (red) as compared to total CD8 T cells (black/grey) of three representative individuals (#KEL12 FLU HLA-A*02 GILGFVFTL, #652 EBV HLA-
B*08 RAKFKQLL and #KEL12 CMV HLA-B*07 TPRVTGGGAM, respectively). (B) Frequencies of Flu, EBV and CMV-specific CD8 T cells expressing 2B4,
CD160, PD-1. Red bars correspond to mean 6 SEM. Statistical significance (P values) in panel B were obtained using One-way ANOVA (Kruskal-Wallis
test) followed by a unpaired Student’s t-test. (C) Expression profiles of 2B4, CD160, PD-1 of CMV, EBV and Flu-specific CD8 T cells. All the possible
combinations of 2B4, CD160 and PD-1 expression are shown on the x axis and frequencies of 2B4, CD160 and PD-1 expression on CD8 and T-cell
populations are shown on the y axis. Combinations of expression are grouped and color-coded on the basis of the number of molecules expressed.
The pie chart summarizes the data, and each slice corresponds to the fraction of T cells expressing a given combination of molecules within the CD8
T-cell populations. Bars correspond to the fractions of distinct T-cell populations within the total T cells. Stars indicate statistical significance (*:P,
0.025; **:P,0,005; ***:P,0.0001) and were calculated using the SPICE software.
doi:10.1371/journal.ppat.1004380.g001
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Figure 2. CD160, but not PD-1 and/or 2B4 expression inversely correlates with CD8 T-cell proliferative capacity. (A–B) Representative
flow cytometric profiles of 2B4, PD-1 and CD160 expression of CMV (#700 CMV HLA-A*02 NLVPMVATV) and Flu (#304 FLU HLA-A*02 GILGFVFTL)
specific CD8 T cells detected by multimer staining (red) as compared to total CD8 T cells (black/grey). (C–D) Representative CMV (#700 CMV HLA-
A*02 NLVPMVATV) and Flu (#MP FLU HLA-A*02 GILGFVFTL) specific CD8 T-cell proliferation capacity assessed by CFSE based assay. (E) Proliferation
index (CFSElow CD8 T-cell frequency/Multimer-specific CD8 T-cell frequency) CMV, EBV and FLU-specific CD8 T cells. Red bars correspond to mean 6
SEM. (F) Correlations between proliferation index (CFSElow CD8 T-cell frequency/Multimer-specific CD8 T-cell frequency; x axes) and the virus-specific
CD8 T-cell subsets distribution (percentage of Multimer-specific CD8 T cells expressing the different combinations of 2B4, PD1 and CD160; y axes).
Statistical significance (P values) in panel E were obtained using One-way ANOVA (Kruskal-Wallis test) followed by a Student’s t-test. P values in F
were obtained using Spearman’s rank correlations.
doi:10.1371/journal.ppat.1004380.g002
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CD160. Of note, the naı¨ve CD8 T-cell population
(CD45RA+CCR7+) was excluded from this analysis. As shown in
the representative flow cytometric profiles and the cumulative data
perforin and granzyme B were significantly enriched in 2B4+ CD8
T-cell population as compared to 2B42 CD8 T-cell populations
(P,0.05) (Fig. 7A–B) consistently with a previous study [25].
Within 2B4+ CD8 T-cell populations, perforin expression was not
significantly different between 2B4+PD-12CD160+ and 2B4+PD-
1+CD1602 CD8 T-cell populations (P= 0.1596). However,
perforin expression was significantly reduced in 2B4+PD-
1+CD160+, 2B4+PD-12CD160+ and 2B4+PD-1+CD1602 CD8
T-cell populations as compared to the 2B4+PD-12CD1602 CD8
Figure 3. Proliferative capacity virus-specific CD8 T-cell populations is influenced by co-inhibitory molecule expression. CD8 T-cell
populations were sorted on the basis of 2B4, PD-1 and CD160 expression, labeled with CFSE and stimulated with (viral) peptides in the presence of
autologous irradiated CD8-depleted PBMCs (ratio CD8/feeder cells 1:10) for 6 days (n = 11). (A) Representative CMV (#1260 CMV HLA-A*01
VTEHDTLLY) and CMV (#1261 CMV HLA-A*02 NLVPMVATV) specific CD8 T-cell proliferation capacity assessed by CFSE based assay. (B) Proliferation
index (CFSElow CD8 T-cell frequency/Multimer-specific CD8 T-cell frequency) of virus-specific CD8 T cells. Red bars correspond to mean 6 SEM. Red
stars indicate statistical significance (P,0.05). Statistical significance (P values) in panel B was obtained using One-way ANOVA (Kruskal-Wallis test)
followed by a Student’s t-test.
doi:10.1371/journal.ppat.1004380.g003
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T-cell population (P= 0.0014, P= 0.0047 and P = 0.0039,
respectively). Interestingly, perforin expression was significantly
reduced in 2B4+PD-1+CD160+ as compared to 2B4+PD-
12CD160+ and 2B4+PD-1+CD1602 CD8 T-cell populations
(P= 0.0092 and P = 0.0201, respectively). Finally, the potential
association between perforin and co-inhibitory molecule expres-
sion was assessed within each differentiated CD8 T-cell subset i.e.
naı¨ve, central memory, effector memory and terminally differen-
tiated effector memory. The representative flow cytometric profiles
and the cumulative data showed that perforin expression was
significantly enriched within 2B4-expressing CD8 T cells in both
EM (P= 0.0011) and TDEM (P,0.0001) (Fig. 7C–D). Interest-
ingly, perforin expression was significantly reduced in CD160-
expressing CD8 T cells in both EM (P= 0.0063) and TDEM
(P= 0.026) and in PD-1-expressing CD8 T cells in both EM
(P= 0.0391) and TDEM (P= 0.00031) (Fig. 7C–D). Taken
together, these data demonstrate that CD8 T-cell populations
expressing CD160 and/or PD-1 harbored reduced perforin
expression, independently of the differentiation state (Fig. 7C–
D). Of note, the percentage of expression of EOMES, T-bet and
CD57 (immunosenescence [26]) was not significantly different
(P.0.05) between 2B4+CD160+PD-12 and 2B4+CD160+PD-1+
CD8 T-cell populations (Fig. S4), suggesting that
2B4+CD160+PD-1+ CD8 T-cell population was not more
immunosenescent than 2B4+CD160+PD-12 CD8 T-cell popula-
tion. Taken together, these data demonstrate that the expression of
CD160 and/or PD-1 on 2B4+ CD8 T cells is associated with a
reduced capacity to express perforin as compared to the
2B4+CD1602PD-12 CD8 T-cell population, independently on
the differentiation state.
CD160 blockade significantly increases virus-specific CD8
T-cell proliferation
In order to assess the relative influence of CD160 signaling as
compared to PD-1 signaling on the virus-specific CD8 T-cell
proliferation capacity, the proliferation capacity of CMV, EBV
Figure 4. Intrinsic proliferation capacity of sorted CD8 T-cell populations expressing the different combinations of 2B4, CD160 and
PD-1. CD8 T-cell populations were sorted on the basis of 2B4, PD-1 and CD160 expression, labeled with CFSE and stimulated in anti-CD3 and anti-
CD28 MAbs coated plate for 6 days (n = 11). The percentage of proliferating CD8 T cells (CFSE low) was assessed by flow cytometry at day 6. (A)
Representative flow cytometric profiles of proliferating CD8 T-cell populations following anti-CD3/CD8 MAbs stimulation. Unstimulated cells
(negative control) are also shown. (B) Percentage of CD8 T-cell proliferation of each CD8 T-cell subset upon 6 days stimulation with a-CD3/CD28
coated mAbs. Red bars correspond to mean 6 SEM. Red stars indicate statistical significance (P,0.05). NS: not significant. Statistical significance (P
values) in panels A and B were obtained using One-way ANOVA (Kruskal-Wallis test) followed by a paired Student’s t-test.
doi:10.1371/journal.ppat.1004380.g004
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and Flu-specific CD8 T cells was evaluated in the presence or in
the absence of 1) blocking anti-CD160 monoclonal antibodies
(mAbs), 2) blocking anti-PD-L1/2 mAbs, 3) combined blocking
anti-CD160 and anti-PD-L1/2 mAbs and 4) isotype controls. Of
note, anti-CD160 MAbs did not show any agonistic potential
either in absence or in presence of TCR signal (data not shown), as
assessed by CD69, CD107a and BCL-2 expression or TNF-a and
IFN-c production (data not shown). The representative flow
cytometric profiles showed that both anti-CD160 and anti-PD-1
mAb treatments individually increased the proliferation capacity
of EBV-specific CD8 T cells (Fig. 8A). In addition, the cumulative
data showed that both anti-CD160 and anti-PD-1 mAb treatments
individually increased the proliferation capacity of CMV, EBV
and Flu-specific CD8 T cells (2.06 fold increase; P,0.0001; and
7.6 fold increase; P,0.0001, respectively) (Fig. 8B–C). The effects
of the combined blockade of CD160 and PD-1 signaling pathways
as compared to PD-1 or CD160 signaling blockade alone on CD8
T-cell proliferation were assessed on virus-specific CD8 T-cell
populations harboring 1) both 2B4+CD1602PD-1+ and
2B4+CD160+PD-12 CD8 T-cell populations (2B4+CD1602PD-
1+ and 2B4+CD160+PD-12 virus-specific CD8 T cells .10%;
N = 5) (Fig. 8D) and 2) containing the highest proportion of
2B4+CD160+PD-1+ CD8 T-cell population (2B4+CD160+PD-1+
virus-specific CD8 T cells .30%; N = 6) (Fig. 8E). The cumulative
data show that the combined blockade of CD160 and PD-1
signaling pathways significantly increased CD8 T-cell proliferation
as compared to PD-1 or CD160 signaling blockade alone, in virus-
specific CD8 T cells containing both 2B4+CD1602PD-1+ and
2B4+CD160+PD-12 CD8 T-cell populations (2B4+CD1602PD-1+
and 2B4+CD160+PD-12 virus-specific CD8 T cells .10%; N = 5)
(P,0.05) (Fig. 8D). However, consistently with the study by Peretz
et al. [18], the combined blockade of CD160 and PD-1 signaling
pathways did not significantly increase CD8 T-cell proliferation as
compared to PD-1 signaling blockade alone, in virus-specific CD8
T cells containing the highest proportion of 2B4+CD160+PD-1+
CD8 T-cell population (2B4+CD160+PD-1+ virus-specific CD8 T
cells .30%; N = 6) (P.0.05) (Fig. 8E). In addition, PD-1 signaling
blockade was significantly more potent on virus-specific CD8 T
cells with dominant 2B42CD1602PD-1+ CD8 T-cell population
as compared to virus-specific CD8 T cells with dominant
2B4+CD1602PD-1+ or 2B4+CD160+PD-1+ CD8 T-cell popula-
tions (10.36 versus 4.06 and 1.95 fold increase; P= 0.0014 and
P= 0.0023, respectively) (Fig. 8F). Of note, PD-1 mean fluorescent
intensity (MFI) was not significantly different between
2B42CD1602PD-1+ and 2B4+CD160+PD-1+ CD8 T-cell popu-
lations (Fig. S5). Interestingly, however, the 2B4+CD160+PD-12
Figure 5. Relative capacity of CD8 T-cell subsets defined by 2B4, CD160 and PD-1 expression to produce IL-2 and IFN-c. CD8 T-cell
responses were analyzed within six CD8 T-cell subsets defined by 2B4, CD160 and/or PD-1 expression. (A) Representative flow cytometric profiles of
CD8 T cells producing IL-2 and/or IFN-c following stimulation of total blood mononuclear cells with SEB in Subject #1096. Unstimulated cells
(negative control) are also shown. (B) Frequencies of IL-2 and IFN-c-producing CD8 T-cell populations. Red bars correspond to mean6 SEM. Red stars
indicate statistical significance (P,0.05). NS: not significant. Statistical significance (P values) in panels A and B were obtained using One-way ANOVA
(Kruskal-Wallis test) followed by a paired Student’s t-test.
doi:10.1371/journal.ppat.1004380.g005
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CD8 T-cell population expressed the highest levels of CD160
(MFI) and 2B4 (MFI) as compared to any other CD8 T-cell
population (Fig. S5). Taken together, these data demonstrate that
a) CD160 and PD-1 signaling negatively regulate TCR-mediated
CD8 T-cell signaling, b) the functional restoration induced by the
blockade of multiple co-inhibitory molecules may be incomplete,
and c) the cells expressing several co-inhibitory molecules are more
profoundly impaired than cells expressing only one co-inhibitory
molecule.
Restoration of CD8 T-cell proliferation by CD160/CD160-
ligand blockade directly correlates with the level of the
ex vivo CD160 expression
Since the expression level of co-inhibitory molecules on virus-
specific CD8 T cells is highly heterogeneous (Fig. 1), the influence
of CD160 and PD-1 signaling blockade was evaluated with regard
to the ex vivo expression levels of CD160 and PD-1. The
representative flow cytometric profiles as well as the cumulative
data showed that CD160 signaling blockade was significantly more
potent in cells harboring high level of CD160 (percentage of virus-
specific CD8 expressing more than 20% of CD160) versus cells
harboring low level of CD160 (percentage of virus-specific CD8
expressing less than 20% of CD160) (P,0.0001) (Fig. 9A–E). In
addition, the degree of restoration of virus-specific CD8 T-cell
proliferation capacity induced by CD160 blockade directly
correlated with the ex vivo proportion of 2B4+CD160+PD-1+ or
2B4+CD160+PD-12 virus-specific CD8 T cells (r = 0.6818;
P= 0.0003 and r = 0.7141; P,0.0001, respectively) (Fig. 9F–G).
Interestingly, the effect of the blockade of PD-1/PD-L1/2
pathway on the degree of the restoration of virus-specific CD8
Figure 6. Combined assessment of co-inhibitory molecule expression and differentiation state. CD8 T-cell differentiation and CD8 T-cell
expression of 2B4, CD160 and/or PD-1 were analyzed. (A) Representative example of flow cytometric profile of CD8 T-cell subsets defined by CCR7
and CD45RA expressing 2B4 and/or CD160. (B) Cumulative analyses (n = 10) of co-inhibitory molecules expression within 3 distinct memory CD8 T-
cell subsets. (C) Cumulative analyses (n = 10) of the differentiation within 6 distinct CD8 T-cell population defined by 2B4, PD-1 and CD160
expression. NS: not significant. Statistical significance (P values) was obtained using One-way ANOVA (Kruskal-Wallis test) followed by a paired
Student’s t-test. Red bars correspond to mean 6 SEM. Red stars indicate statistical significance (P,0.05).
doi:10.1371/journal.ppat.1004380.g006
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Figure 7. Expression levels of perforin and granzyme B in CD8 T-cell subsets defined by the expression of 2B4, CD160 and PD-1.
CD8 T-cell responses were analyzed within six CD8 T-cell subsets defined by 2B4, CD160 and/or PD-1 expression. (A) Representative flow cytometric
profiles of CD8 T cells expressing perforin and/or granzyme B ex vivo. (B) Frequencies of CD8 T cells expressing perforin and granzyme B. (C)
Representative flow cytometric profiles of differentiated CD8 T-cell subsets defined by the CCR7 and CD45RA expressing perforin, 2B4, CD160 and
PD-1. (D) Cumulative analyses (n = 10) representing the expression of perforin differentiated CD8 T-cell subsets in function of CD160 expression. Red
bars correspond to mean 6 SEM. Red stars indicate statistical significance (P,0.05). NS: not significant. Statistical significance (P values) in panels B
and D were obtained using One-way ANOVA (Kruskal-Wallis test) followed by a paired Student’s t-test.
doi:10.1371/journal.ppat.1004380.g007
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T-cell proliferation capacity was not associated with the ex vivo
proportion of 2B4+CD160+PD-1+, 2B4+CD1602PD-1+ or
2B42CD1602PD-1+ virus-specific CD8 T cells (r =20.1611;
P.0.05, and r =20.2566; P.0.05 and r = 0.2949; P.0.05,
respectively) (Fig. 9H–J).
CD160 expression is not up-regulated upon T-cell
activation or proliferation
Previous studies have indicated that PD-1 expression
increased following T-cell stimulation and activation [27].
However, the regulation of CD160 expression following T-cell
activation or proliferation remains unclear. We then evaluated
the expression levels of PD-1 and CD160 co-inhibitory
molecules following TCR stimulation using flow cytometry.
Briefly, cells were stained with CFSE, stimulated with anti-CD3
plus anti-CD28 Abs and the expression levels of PD-1 and
CD160 were assessed by flow cytometry at day 0, 1, 2, 3 and 5.
Representative flow cytometric profiles as well as cumulative
data showed that CD160 expression was down-regulated in
CD8 T cells upon T-cell activation and proliferation, while PD-
1 expression increased (Fig. 10A–B).
Discussion
Several studies have demonstrated that the increased expression of
co-inhibitory molecules including PD-1, 2B4 and CD160 during
chronic viral infections is associated with CD8 T-cell dysfunction
[2,17,18,28]. However, the relative contribution of individual co-
inhibitory molecules in the T-cell functional impairment remains
unclear.
In the present study, we have evaluated the impact of individual
co-inhibitory molecules expression such as 2B4, PD-1 and CD160
on virus-specific CD8 T-cell functions. To address this issue, we
have performed both phenotypic and functional characterization
of Flu, EBV and CMV-specific CD8 T cells in healthy individuals.
We show that EBV and CMV-specific CD8 T cells contained
higher frequency of cells co-expressing 2B4, CD160 and PD-1 in
different combinations while Flu-specific CD8 T cells had higher
frequencies of triple negative, single PD-1 or dual PD-1/2B4 CD8
T-cell populations. In particular, the percentage of CD160
expression was significantly lower in Flu-specific CD8 T cells
than in CMV or EBV-specific CD8 T cells. Interestingly, the level
of total PD-1 was not significantly different in Flu, EBV or CMV-
specific CD8 T cells. These data suggest that CD160 expression in
virus-specific CD8 T cells is associated with chronic virus
infections such as EBV and CMV. Of note, co-inhibitory molecule
expression on virus-specific CD8 T cells are likely influenced by
the pathogen characteristics, the type of viral infection (cleared
versus chronic viral infections), the cytokine milieu, the nature of
the infected cell population.
Proliferation capacity is one of the first CD8 T-cell functions lost
during the progression to CD8 T-cell exhaustion [11–14,20]. In this
regard, we assessed which pattern of co-inhibitory molecules
expression had the greater impact on the proliferation capacity of
virus-specific CD8 T cells. We showed that the proportion of total
CD160 expression and in particular of 2B4+CD160+PD-1+ or
2B4+CD160+PD-12 CD8 T-cell populations inversely correlated
with the proliferation capacity thus suggesting that CD160 expression
was associated with reduced CD8 T-cell proliferation capacity
independently of PD-1 expression. The reduced proliferation
capacity of sorted virus-specific 2B4+CD160+PD-1+,
2B4+CD160+PD-12, 2B4+CD1602PD-1+, 2B4+CD1602PD-12
CD8 T-cell populations as compared to 2B42CD1602PD-1+ and
2B42CD1602PD-12 CD8 T-cell populations suggest that the
proliferation capacity CD8 T cells is influenced by co-inhibitory
molecule expression.
The intrinsic proliferation capacity of the different CD8 T-cell
populations was then evaluated and showed that CD8 T cells
expressing CD160 and/or PD-1 were endowed with reduced
proliferation capacity as compared to CD160 and PD-1 negative
CD8 T-cell populations. Interestingly, the proliferation capacity of
2B4+CD160+PD-1+ and 2B4+CD160+PD-12 CD8 T cells was not
significantly different, suggesting that CD160 expressing CD8 T
cells are endowed with reduced proliferation capacity, indepen-
dently of PD-1 expression.
We then showed that 2B4+CD160+PD-1+ or 2B4+CD160+PD-
12 CD8 T-cell populations also had a reduced capacity to produce
IL-2, IFN-c and perforin as compared to CD1602 CD8 T-cell
populations demonstrating that CD160+ CD8 T-cell populations
were more functionally impaired than CD1602 CD8 T-cell
populations independently of PD-1 expression. Since reduced IL-2
production capacity is commonly associated with increased
differentiation state [21], the differentiation state was evaluated
together with the expression of co-inhibitory molecules. We
showed that co-inhibitory molecule expression is associated with
differentiation state [22]. However in depth analyses indicated that
significant differences are present within each CD8 T-cell
populations, particularly among PD-1 and/or CD160-expressing
populations and suggested that CD8 T-cell functions might be
modulated by co-inhibitory molecule expression.
The functions of CD160 are complex, and still remain under
debate, with potentially various roles i.e. either stimulatory or
inhibitory, depending on the cell type, the expression of the ligands
(HVEM or MHC class I) [29–32] and the fact that CD160 exist in
two isoforms (spliced variants) with and without transmembrane
(TM) domain [33,34]. In order to determine whether CD160/
CD160-ligand interactions could negatively regulate CD8 T-cell
signaling, virus-specific CD8 T-cell proliferation was assessed in
the presence or in the absence of mAbs that block CD160/
CD160-ligand signaling. Since two molecules have been shown to
interact with CD160 i.e. HVEM (member of the TNF receptor
superfamily) and MHC class I molecules [29–32], blocking anti-
CD160 Abs that prevent both possible interactions were used
[31,35]. Of note, HVEM is broadly distributed and expressed in
hematopoietic and non-hematopoietic cells [36]. The ability of
anti-CD160 Abs to increase virus-specific CD8 T-cell proliferation
demonstrated that CD160 signaling negatively regulates TCR-
mediated CD8 T-cell signaling. Interestingly, the level of
restoration of virus-specific CD8 T-cell proliferation capacity
induced by CD160 blockade was significantly more potent in cells
harboring high level of CD160 and directly correlated with the ex
vivo proportion of CD160 expression independently of PD-1
expression. These results suggested that 2B4+CD160+PD-1+ and
2B4+CD160+PD-12 CD8 T-cell populations were both rescued by
CD160/CD160-ligands signaling blockade.
We then showed that 2B4+CD160+PD-1+, 2B4+CD160+PD-12
and 2B4+CD1602PD-1+ CD8 T-cell populations had reduced
expression of perforin as compared to 2B4+CD1602PD-12 CD8
T-cell population, suggesting that the expression of CD160 and/or
PD-1 on 2B4+ CD8 T cells is associated with a reduced capacity to
express perforin. Interestingly, CD160 signaling is commonly
associated with enhanced NK-cell cytotoxic activity [30–32]
suggesting that CD160 might have distinct functions depending
upon the cell subset considered. Indeed, CD160 is a GPI-anchored
protein lacking both transmembrane (TM) and intracytoplasmic
domains [33,34]). Therefore, the signaling cascade(s) triggered
following CD160/CD160-ligand interactions might depend on the
cell-type, the ligand (either HVEM or MHC class I molecules), the
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density of CD160 expression, the potential co expression with
CD160-TM and on the downstream adaptor proteins and/or
signaling molecules, which are still not fully characterized [37,38].
We hypothesize that in CD8 T cells, CD160 might be associated
with a specific phosphatase that might reduce the signal triggered
following TCR/co-stimulatory receptors engagement. In addition,
CD160 exists in two isoforms (spliced variants) with and without
TM domain [33,34]. While NK cells can express both isoforms i.e.
CD160 and CD160 TM, that are modulated following IL-15
stimulation [34], CD8 T cells do not express CD160 TM directly
ex vivo nor following IL-15 or TCR stimulation ([34] and Fig. S6).
This feature may explain the dichotomic role of CD160 i.e.
involved in CD8 T-cell negative regulation and NK-cell cytotoxic
activity [17,18,30–32].
As previously demonstrated PD-1 signaling blockade by anti-
PD-L1/2 Abs significantly increased virus-specific CD8 T-cell
proliferation [12,13,17]. However, the PD-1 signaling blockade
was significantly more potent on virus-specific CD8 T cells
containing predominant 2B42CD1602PD-1+ CD8 T-cell popu-
lation as compared to virus-specific CD8 T cells with predominant
2B4+CD1602PD-1+ or 2B4+CD160+PD-1+ CD8 T-cell popula-
tions. These data suggest that cells expressing several co-inhibitory
molecules are more profoundly impaired than cells expressing only
one co-inhibitory molecule. Along the same line, PD-1 signaling
blockade was on average more potent than CD160 signaling
blockade in restoring virus-specific CD8 T-cell proliferation.
Interestingly, the combined anti-CD160/anti-PD-L1/2 treatment
showed additive effects only on virus-specific CD8 T cells
containing both 2B4+CD1602PD-1+ or 2B4+CD160+PD-12
CD8 T-cell populations, but not on virus-specific CD8 T cells
co-expressing PD-1 and CD160. We postulate that cells expressing
both co-inhibitory receptors might be intrinsically impaired, and
their functions might be only partially reversible. Of note, PD-1
mean fluorescent intensity (MFI) was not significantly different
between 2B42CD1602PD-1+ and 2B4+CD160+PD-1+ CD8 T-
cell populations (Fig. S5), suggesting that the difference in the
restoration of proliferation capacity was not due to PD-1
expression level but likely on a different intrinsic capacity of the
cells to proliferate.
Taken together, these data suggest that the functional restora-
tion induced by the blockade of several co-inhibitory molecules
may be incomplete and that cells expressing several co-inhibitory
molecules are more profoundly impaired than cells expressing only
one co-inhibitory molecule.
Consistently with a previous study [39], we showed that PD-1
expression was up-regulated following T-cell activation and
proliferation. However, CD160 expression was down-regulated
following T-cell activation and proliferation. Thus, PD-1/PD-1-
Ligand blockade may have an effect on both cells expressing PD-1
at the time of stimulation and on proliferating cells while CD160
blockade may only act on cells expressing CD160 at the time of
stimulation. The differences in CD160 and PD-1 expression may
contribute to understand 1) the higher potency observed of the
PD-1/PD-1-Ligand blockade as compared to CD160 blockade in
restoring virus-specific CD8 T-cell proliferation and 2) the absence
of correlation between the level of restoration of virus-specific CD8
T-cell proliferation capacity induced by PD-1/PD-L1 blockade
and the ex vivo proportion of PD-1-expressing CD8 T cells.
Interestingly, the 2B42CD1602PD-1+ CD8 T-cell population
was significantly enriched in Flu-specific CD8 T cells as compared
to EBV or CMV-specific CD8 T cells, and had higher IL-2
production capacity than all the other populations investigated.
Furthermore, the 2B42CD1602PD-1+ CD8 T-cell population
expressed similar level of PD-1 (MFI) compared to the
2B4+CD160+PD-1+ CD8 T-cell population. The percentage of
2B42CD1602PD-1+ CD8 T-cell population expressing EOMES,
Tbet and CD57 was significantly lower than 2B4+CD1602PD-1+
and 2B4+CD160+PD-1+ CD8 T-cell populations. These data
suggest that 2B42CD1602PD-1+ CD8 T cells may be less
functionally impaired than 2B4+CD1602PD-1+ and
2B4+CD160+PD-1+ CD8 T-cell populations.
In conclusion, while accumulation of different immune check
point blockers is clearly associated with progressive dysfunction,
the present study demonstrates that CD160-mediated regulation
of CD8 T-cell functions is independent of PD-1 expression thus
providing evidence that CD160 contributes to the regulation of
CD8 T-cell functions.
Materials and Methods
Study group, ethics statement and cell isolation
Forty subjects were recruited in this study. Blood samples were
obtained at the local blood bank (Centre de transfusion sanguine
(CTS), Lausanne, Switzerland). The use of samples used in this
study was approved by the Institutional Review Board of the CTS,
and all subjects gave written informed consent. Only individuals
with no sign of HIV, HAV, HBV and HCV infections were
included. Blood mononuclear cells were isolated as previously
described [40].
Antibodies
The following monoclonal antibodies (mAbs) were used in
different combinations. CD8-PB, CD3-APC-H7, PD-1-PECy7,
PD-1-PB, IFN-c-AF700, IL-2-PE, CD4-PB, granzyme B-AF700,
perforin-APC were purchased from Becton Dickinson (BD, San
Diego, CA), CD45RA-ECD, CD4-ECD from Beckman Coulter
(Fullerton, CA, USA), CCR7-FITC from R&D Systems (Minne-
apolis, MN, USA), 2B4-PECY5.5, CD160-APC, CD160-PE from
BioLegend (San Diego, CA, USA), CD4-eFluor650NC, CD8-
eFluor625NC from eBioscience.
Ex vivo analyses of CD8 T cells
Cryo-preserved blood mononuclear cells (1–26106) cells were
washed, stained (30 min; 4uC) for dead cells using the Aqua
Figure 8. CD160 blockade significantly increases virus-specific CD8 T-cell proliferation. (A) Representative example of EBV-specific CD8
T-cell proliferation (#675 EBV HLA-B*08 RAKFKQLL) in presence or in absence of anti-CD160 mAbs and/or anti-PDL-1/2 mAbs assessed by CFSE-based
assay. (B) Percentage of CMV, EBV and Flu-specific CD8 T-cell proliferation in presence or not of anti-CD160 mAb (N= 21). (C) Percentage of CMV, EBV
and Flu-specific CD8 T-cell proliferation in presence or not of anti-PDL-1/2 mAb (N= 21). (D) Fold increase in the frequency of CFSE low CD8 T cells in
presence of anti-CD160 and/or anti-PDL-1/2 mAb as compared to untreated virus-specific CD8 T cells from virus-specific CD8 T-cell populations
harboring both 2B4+CD1602PD-1+ and 2B4+CD160+PD-12 CD8 T-cell populations (2B4+CD1602PD-1+ and 2B4+CD160+PD-12 virus-specific CD8 T
cells .10%) (N= 5) or (E) from virus-specific CD8 T-cell populations containing the highest proportion of 2B4+CD160+PD-1+ CD8 T-cell population
(2B4+CD160+PD-1+ virus-specific CD8 T cells .30%) (N= 6). (F) Fold increase in the frequency of CFSE low CD8 T cells in presence of anti-PDL-1/2
mAb on virus-specific CD8 T cells dominated by 2B42CD1602PD-1+, 2B4+CD1602PD-1+ or 2B4+CD160+PD-1+ CD8 T-cell populations. Red bars
correspond to mean 6 SEM. Statistical significance (P values) were obtained using One-way ANOVA (Kruskal-Wallis test) (panel D–F) followed by a
paired Student’s t-test (panels B–C), Wilcoxon Signed Rank test (D–E), or unpaired Student’s t-test (panels F).
doi:10.1371/journal.ppat.1004380.g008
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LIVE/DEAD stain kit (Invitrogen) and, when required, stained
with appropriately tittered peptide-MHC class I multimer
complexes at 4uC for 309 in Ca2+-free media as described [24].
Cells were then washed and stained (30 min; 4uC) with the
following mAbs: CD3, CD8, CD4, PD-1, CD160 and 2B4.
Virus-specific CD8 T-cell proliferation
Overnight-rested cryopreserved blood mononuclear cells (106 in
1 ml of complete medium) were stained with 0.25 mM 5,6-
carboxyfluorescein succinimidyl ester (CFSE, Molecular Probes,
USA) as previously described [41], and stimulated with CMV,
EBV or Flu peptides (1 mg/ml), 200 ng/ml of SEB (positive
control; Sigma-Aldrich) or left unstimulated (negative control) in
presence or in absence of anti-CD160 (2 mg/ml; MBL) and/or
anti-PD-L1/2 (10 mg/mL) [13]. At day 6, cells were harvested and
stained (4uC; 20 min) using the violet or aqua LIVE/DEAD stain
kit (Invitrogen) and Abs (4uC; 30 min) to CD3, CD4, CD8.
Frequencies of proliferating CFSElow CD8 T cells were assessed by
flow cytometry.
Evaluation of the kinetic of CD160 and PD-1 expression
on CD8 T cells after activation and expansion
Cryopreserved blood mononuclear cells (106 in 1 ml of
complete medium) were stained with 0.25 mM 5,6-carboxyfluor-
Figure 9. Restoration of CD8 T-cell proliferation by CD160/CD160-ligand blockade directly correlates with the level of the ex vivo
CD160 expression. (A–B) Representative flow cytometric profile of 2B4, CD160 and PD-1 expression of CMV (#215 CMV HLA-A*02 NLVPMVATV)
and EBV (#762 EBV HLA-B*07 RPPIFIRRL)-specific CD8 T cells detected by multimer staining (red) compared with total CD8 T cells (black/grey). (C–D)
Representative examples of CMV (#215 CMV HLA-A*02 NLVPMVATV) and EBV (#762 EBV HLA-B*07 RPPIFIRRL)-specific CD8 T-cell proliferation in
presence or not of anti-CD160 mAbs assessed by CFSE-based assay. (E) Impact of CD160 expression on the restoration of CD8 T-cell proliferation by
CD160/CD160-ligand blockade. (F–G) Correlation between fold increase in proliferation capacity (y axes) upon CD160 blockage and percentage of
2B4+CD160+PD-1+ or 2B4+CD160+PD-12 virus-specific CD8 T cells. (H–J) Correlation between fold increase in proliferation capacity (y axes) upon PDL-
1/2 blockage and percentage of 2B4+CD160+PD-1+, 2B4+CD1602PD-1+ or 2B42CD1602PD-1+ virus-specific CD8 T cells (x axes). Statistical significance
(P values) in B–I were obtained using Spearman’s rank correlations.
doi:10.1371/journal.ppat.1004380.g009
Figure 10. Kinetic of CD160 or PD-1 expression on CD8 T cells stimulated upon T-cell stimulation. (A) Representative flow cytometric
profile of CD160 and PD-1 expression on CD8 T cells after 0, 24, 48, 72 and 120 hours of stimulation with anti-CD3/anti-CD28 magnetic beads. CD8 T-
cell proliferation was also measured by CFSE-based assay at 48, 72 and 120 hours after stimulation. (B) Cumulative data of CD160 or PD-1-expressing
CD8 T-cell frequencies at distinct time points after stimulation. Red bars correspond to mean 6 SEM.
doi:10.1371/journal.ppat.1004380.g010
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escein succinimidyl ester (CFSE, Molecular Probes, USA) as
previously described [41], and stimulated with anti-CD3/anti-
CD28 magnetic beads (Dynabeads, Invitrogen). The expression of
CD160 and PD-1 on CD8 T cells was evaluated after 0, 24, 48, 72
and 120 hours of stimulation by anti-CD3/anti-CD28 magnetic
beads. CD8 T-cell proliferation was also evaluated by CFSE
dilution.
Intracellular cytokine staining (ICS)
PBMC were stimulated overnight in complete media (RPMI
(Invitrogen), 10% fetal calf serum (FCS; Invitrogen), 100 mg/ml
penicillin, 100 unit/ml streptomycin (BioConcept)) with Staphy-
loccocus enterotoxin B (SEB; 250 ng/mL) or left unstimulated
(negative control) in the presence of Golgiplug (1 ml/ml; BD) and
anti-PD1, anti-CD160 and anti-2B4 mAbs. At the end of the
stimulation period, cells were washed, stained (20 min; 4uC) for
dead cells using the Aqua LIVE/DEAD stain kit (Invitrogen),
permeabilized (20 min; 20uC) (Cytofix/Cytoperm, BD) and
stained (30 min; 20uC) with mAbs to CD3, CD8, CD45RA,
CCR7, IFN-c and IL-2 [42].
Perforin and granzyme B expression assessment
PBMC were washed, stained (20 min; 4uC) for dead cells using
the Aqua LIVE/DEAD stain kit (Invitrogen). Cells were then
washed and stained (30 min; 4uC) with the following mAbs: CD3,
CD8, PD-1, 2B4, CD160, CCR7 and CD45RA. Cells were then
permeabilized (20 min; 20uC) (Cytofix/Cytoperm, BD) and
stained (30 min; 20uC) with mAbs to perforin and granzyme B
[23].
CD45RA, CCR7, EOMES, T-bet and CD57 expression
assessment
PBMC were washed, stained (20 min; 4uC) for dead cells using
the Aqua LIVE/DEAD stain kit (Invitrogen). Cells were then
washed and stained (30 min; 4uC) with the following mAbs in
different combinations: CD3, CD8, PD-1, 2B4, CD160 and CD57
or CD3, CD8, PD-1, 2B4, CD160, CCR7 and CD45RA. Cells
were then permeabilized (1 h; 4uC) (Foxp3 Fixation/Permeabili-
zation Kit; eBioscience) and stained (30 min; 4uC) with mAbs to
EOMES and T-bet.
Proliferation of CD8 T-cell populations
Cryopreserved CD8 T cells (30–406106 cells) previously
selected by MACS cell separation (Miltenyi kit) were washed,
stained (20 min; 4uC) for dead cells using the Aqua LIVE/DEAD
stain kit (Invitrogen). Cells were then washed and stained (30 min;
4uC) with the following mAbs: CD8, PD-1, 2B4, CD160,
CD45RA, CCR7. CD8 T-cell populations were sorted by BD
FACSAria III on the basis of 2B4, PD-1 and CD160 expression
after exclusion of naı¨ve T cells (CD45RA+CCR7+). Sorted
populations were labeled with CFSE and stimulated with viral
peptides (1 mg/mL) in the context of irradiated (40 Gy) autologous
CD8-depleted PBMCs (ratio CD8/feeder cells 1:10) or in anti-
CD3 (10 ug/ml) and anti-CD28 (0.5 ug/ml) mAbs coated plate or
left unstimulated. Proliferation was assessed at day 6 by flow
cytometry. Cells were washed, stained (20 min; 4uC) for dead cells
using the Aqua LIVE/DEAD stain kit (Invitrogen). Cells were
then washed and stained (30 min; 4uC) with anti-CD8 and anti-
CD3 mAbs.
Assessment of CD160 and CD160-TM expression
CD160 and CD160-TM expression were assessed both ex vivo
and after in vitro expansion. To assess their expression ex vivo
PBMC were washed, stained (20 min; 4uC) for dead cells using the
Aqua LIVE/DEAD stain kit (Invitrogen). Cells were then washed
and stained (30 min; 4uC) with the following mAbs: CD8, CD3,
CD56, CD160, CD160-TM (rabbit unconjugated). Cells were
then washed and stained (30 min; 4uC) with anti-rabbit secondary
Ab. To assess their expression after in vitro expansion PBMC were
labeled with CFSE and stimulated with IL-15 (50 ng/mL) or with
anti-CD3 (10 ug/ml) and anti-CD28 (0.5 ug/ml) mAbs coated
plate. CD160 and CD160-TM expression were assessed at day 6
by flow cytometry. Cells were washed, stained (20 min; 4uC) for
dead cells using the Aqua LIVE/DEAD stain kit (Invitrogen).
Cells were then washed and stained (30 min; 4uC) with the
following mAbs: CD8, CD3, CD56, CD160, CD160-TM (rabbit
unconjugated). Cells were then washed and stained (30 min; 4uC)
with anti-rabbit secondary Ab.
Flow cytometry analyses
Cells were fixed with CellFix (BD), acquired on an LSRII
SORP (4 lasers: 405, 488, 532 and 633 nm) and analyzed using
FlowJo (version 8.8.2) (Tree star Inc, Ashland, OR, USA) and
SPICE 4.2.3. When required, analysis and presentation of
distributions was performed using SPICE version 5.1, downloaded
from ,http://exon.niaid.nih.gov/spice. [43]. The number of
lymphocyte-gated events ranged between 56105 and 106 in the
flow cytometry experiments.
Statistical analyses
Statistical significance (P values) was obtained using one-way
ANOVA (Kruskal-Wallis test) followed by Student’s t test for
multiple comparisons or a Spearman rank test for correlations
using GraphPad Prism version 5.0 (San Diego, CA). Statistical
analyses of global cytokine profiles (pie charts) were performed by
partial permutation tests using the SPICE software as described
[43].
Supporting Information
Figure S1 Expression levels of 2B4, CD160 and PD-1 on
CD8 T cells and fluorescence minus one (FMO) for each
of this molecule. Flow cytometric profiles of CD8 T cells
expressing PD-1, CD160 and 2B4 ex vivo. Representative example
(healthy individual #304) of co-inhibitory molecules expression by
CD8 T cells and the respective FMO for each molecule are shown.
(TIF)
Figure S2 Mean fluorescent intensity (MFI) of CD2B4,
CD160 and PD-1 on total CD8 T cells and virus-specific
CD8 T cells. The MFI of 2B4, PD-1 and CD160 expression on
total CD8 T cells in 22 individuals was evaluated using
polychromatic flow cytometry. (A) Cumulative data of the MFI
of 2B4, PD-1 and CD160 expression within total CD8 T cells. (B)
Ratio between the MFI of 2B4, PD-1 and CD160 expression in
Flu, EBV and CMV-specific CD8 T cells and total CD8 T cells.
(TIF)
Figure S3 CD160, but not PD-1 and/or 2B4 expression
inversely correlates with CD8 T-cell proliferative capac-
ity. Correlations between proliferation index (CFSElow CD8 T-
cell frequency/Multimer-specific CD8 T-cell frequency; x axes)
and the virus-specific CD8 T-cell subsets distribution (percentage
of Multimer-specific CD8 T cells expressing the 2B4, PD1 and
CD160; y axes.
(TIF)
Figure S4 Expression of EOMES, T-bet and CD57 on
CD8 T-cell subsets discriminated by the expression of
CD160 Expressing-CD8 T Cells Are Functionally Impaired
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2B4, CD160 and PD-1. (A) Representative example (#1074)
and cumulative analyses (n = 7) of EOMES and T-bet expression
on distinct CD8 T-cell subsets. (B) Representative example
(#1093) and cumulative analyses (n = 10) of CD57 expression on
distinct CD8 T-cell subsets. Red bars correspond to mean6 SEM.
Red stars indicate statistical significance (P,0.05). NS: not
significant. Statistical significance (P values) was obtained using
One-way ANOVA (Kruskal-Wallis test) followed by a paired
Student’s t-test.
(TIF)
Figure S5 Mean fluorescence intensity (MFI) of 2B4,
CD160 and PD-1 on CD8 T-cell subsets discriminated by
the expression of 2B4, CD160 and PD-1. Cumulative data of
the mean fluorescence intensity of 2B4, CD160 and PD-1 on
distinct CD8 T-cell subsets. Red bars correspond to mean6 SEM.
(TIF)
Figure S6 Assessment of CD160 and CD160-TM expres-
sion. The expression of CD160 and CD160-TM was evaluated
by flow cytometry directly ex vivo or after in vitro expansion of
NK cells (CD32CD56+) and/or CD8 T cells (CD3+CD8+). (A)
Representative flow cytometric profile of the CD160 and CD160-
TM expression ex vivo by NK cells and CD8 T cells. (B)
Representative flow cytometric profile of the CD160-TM
expression after 5 days stimulation with IL-15 and/or anti-
CD3/CD28 MAbs by NK cells and CD8 T cells.
(TIF)
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